Financial Counselors Inc’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-506
Closed -$208K 543
2019
Q1
$208K Buy
+506
New +$208K 0.01% 484
2016
Q1
Sell
-1,846
Closed -$1M 460
2015
Q4
$1M Buy
1,846
+93
+5% +$50.4K 0.06% 250
2015
Q3
$815K Buy
1,753
+843
+93% +$453K 0.06% 261
2015
Q2
$464K Buy
910
+1
+0.1% +$488 0.03% 324
2015
Q1
$410K Sell
909
-782
-46% -$331K 0.03% 345
2014
Q4
$694K Buy
1,691
+15
+0.9% +$5.9K 0.04% 286
2014
Q3
$604K Buy
1,676
+49
+3% +$16.4K 0.04% 310
2014
Q2
$460K Sell
1,627
-401
-20% -$119K 0.03% 328
2014
Q1
$609K Buy
2,028
+694
+52% +$214K 0.04% 299
2013
Q4
$367K Buy
1,334
+112
+9% +$32.2K 0.03% 330
2013
Q3
$382K Sell
1,222
-42
-3% -$11K 0.03% 317
2013
Q2
$284K Buy
+1,264
New +$294K 0.02% 336

Other funds holding REGN

Financial Counselors Inc's REGN Position: Q2 2019 in Review

Financial Counselors Inc sold out of Regeneron Pharmaceuticals (REGN) in Q2 2019, closing a stake of 506 shares — an estimated $208K sold.

Financial Counselors Inc first reported a position in REGN in Q2 2013 and held it in 12 quarters. The position peaked at $1M in Q4 2015. 658 funds tracked by Wall St. Rank hold REGN as of Q2 2019.

  • Financial Counselors Inc reported no remaining Regeneron Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
  • Financial Counselors Inc sold 506 Regeneron Pharmaceuticals shares in Q2 2019, an estimated $208K.
  • Financial Counselors Inc first reported a position in Regeneron Pharmaceuticals in Q2 2013 and held it in 12 quarters.
  • Financial Counselors Inc's Regeneron Pharmaceuticals position peaked at $1M in Q4 2015.
  • 658 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2019.

Based on Financial Counselors Inc's 13F filing for Q2 2019, filed 14 Aug 2019.